$1.50? Sounds like you just look at charts and do little DD. Nothing wrong with that and I'm sure it is profitable. But the company's revenue is on the incline and the newly approved X will add to the revenue stream. The market cap at $1.3B is slightly bloated for its current sales but it is justified by the potential of X.